Patents by Inventor Sarah ASHLEY

Sarah ASHLEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210338718
    Abstract: Methods of treating, reducing the risk of, preventing, or alleviating a symptom of a pulmonary disease or condition, reducing or suppressing inflammation in the lung, and promoting lung repair, by pulmonary administration of a cerium oxide nanoparticle composition.
    Type: Application
    Filed: September 27, 2019
    Publication date: November 4, 2021
    Inventors: Kenneth LIECHTY, Carlos ZGHEIB, Sarah Ashley HILTON
  • Patent number: 11058657
    Abstract: The invention relates to PUFA, vitamin E, vitamin D and the protein bound amino acids glycine, arginine and tryptophan as active ingredients for use in therapy of cancer patients, wherein an effective amount of said active ingredients is administered in the form of a nutritional composition comprising a) a lipid component providing 40-50 EN % based on the total energy of the nutritional composition, wherein 12-16 EN % based on the total energy of the nutritional composition is provided by PUFA, b) 4.0-8.0 mg/100 mL alpha-TE vitamin E, c) 5.0-12.0 ?g/100 mL vitamin D, d) 2.5-4.5 g/100 mL glycine, e) 0.5-1.5 g/100 mL arginine, and f) at least 0.02 g/100 mL tryptophan.
    Type: Grant
    Filed: November 16, 2017
    Date of Patent: July 13, 2021
    Assignee: Fresenius Kabi Deutschland GmbH
    Inventors: Edmundo Brito-De-La Fuente, Ericka Pestana, Sarah Ashley-Maguire, Jose Maria Mainou-Sierra, Maria Fernanda Martinez-Bock, Stephanie Reichart
  • Patent number: 10961275
    Abstract: The present invention relates to methods of improving the environment within a poultry farming facility including reducing ammonia production in a poultry facility, inhibiting urease enzymes in poultry litter, reducing levels of pathogenic bacteria in poultry litter, improving productivity of poultry farms, reducing or preventing pododermatitis in poultry reared in mass production poultry facilities and controlling pests in poultry litter. Compositions, suitable for use in such methods, comprising at least one microorganism of the genus Bacillus and at least one biosurfactant wherein the biosurfactant is present in an amount of 2 mg/L to 7000 mg/L are also described.
    Type: Grant
    Filed: February 12, 2018
    Date of Patent: March 30, 2021
    Assignee: Global Bioprotect IP Pty Ltd
    Inventors: Michael Paul Bralkowski, Sarah Ashley Brooks, Stephen M. Hinton, David Matthew Wright, Shih-Hsin Yang
  • Patent number: 10836597
    Abstract: A holding system and methods, systems, and apparatuses for constructing, assembling, and using the holding system are disclosed. The holding system can include an arbor bushing. The arbor bushing can include a head portion. The holding system can also include a plate attached to the arbor bushing. A pad can be attached to the plate. The head portion of the arbor bushing extends outward beyond a surface of the pad.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: November 17, 2020
    Assignee: Southwire Company, LLC
    Inventors: Roy Savoy Bearden, Sarah Ashley Strandell, Timothy Francis Reid
  • Publication number: 20200330688
    Abstract: Devices used to deliver a medical fluid and/or medicament are disclosed herein. The devices may be configured to deliver an accurate volume of fluid and/or medicament. The devices may include a syringe having a barrel member and a plunger member comprising a detent to couple with a retention member of the barrel member to restrict retraction of the plunger member from a locked state due to backpressure.
    Type: Application
    Filed: April 17, 2020
    Publication date: October 22, 2020
    Inventors: David W. Johnson, Sarah Ashley Spangler
  • Publication number: 20200061013
    Abstract: The invention relates to PUFA, vitamin E, vitamin D and the protein bound amino acids glycine, arginine and tryptophan as active ingredients for use in therapy of patients with sarcopenia and/or frailty or pre-sarcopenic and/or pre-frail patients, wherein an effective amount of said active ingredients is administered in the form of a nutritional composition comprising a) a lipid component providing 40-50 EN % based on the total energy of the nutritional composition, wherein 12-16 EN % based on the total energy of the nutritional composition is provided by PUFA, b) 4.0-8.0 mg/100 mL alpha-TE vitamin E, c) 5.0-12.0 ?g/100 mL vitamin D, d) 2.5-4.5 g/100 mL glycine, e) 0.5-1.5 g/100 mL arginine, and f) at least 0.02 g/100 mL tryptophan.
    Type: Application
    Filed: November 16, 2017
    Publication date: February 27, 2020
    Inventors: Edmundo BRITO-DE-LA-FUENTE, Ericka PESTANA, Stephanie REICHART, Maria Fernanda MARTINEZ-BOCK, Sarah ASHLEY, Jose Maria MAINOU-SIERRA
  • Publication number: 20190374495
    Abstract: The invention relates to PUFA, vitamin E, vitamin D and the protein bound amino acids glycine, arginine and tryptophan as active ingredients for use in therapy of cancer patients, wherein an effective amount of said active ingredients is administered in the form of a nutritional composition comprising a) a lipid component providing 40-50 EN % based on the total energy of the nutritional composition, wherein 12-16 EN % based on the total energy of the nutritional composition is provided by PUFA, b) 4.0-8.0 mg/100 mL alpha-TE vitamin E, c) 5.0-12.0 ?g/100 mL vitamin D, d) 2.5-4.5 g/100 mL glycine, e) 0.5-1.5 g/100 mL arginine, and f) at least 0.02 g/100 mL tryptophan.
    Type: Application
    Filed: November 16, 2017
    Publication date: December 12, 2019
    Inventors: Edmundo BRITO DE LA FUENTE, Ericka PESTANA, Sarah ASHLEY-MAGUIRE, José Maria MAINOU-SIERRA, Maria Fernanda MARTINEZ-BOCK, Stephanie REICHART
  • Publication number: 20180170968
    Abstract: The present invention relates to methods of improving the environment within a poultry farming facility including reducing ammonia production in a poultry facility, inhibiting urease enzymes in poultry litter, reducing levels of pathogenic bacteria in poultry litter, improving productivity of poultry farms, reducing or preventing pododermatitis in poultry reared in mass production poultry facilities and controlling pests in poultry litter. Compositions, suitable for use in such methods, comprising at least one microorganism of the genus Bacillus and at least one biosurfactant wherein the biosurfactant is present in an amount of 2 mg/L to 7000 mg/L are also described.
    Type: Application
    Filed: February 12, 2018
    Publication date: June 21, 2018
    Inventors: Michael Paul Bralkowski, Sarah Ashley Brooks, Stephen M. Hinton, David Matthew Wright, Shih-Hsin Yang
  • Publication number: 20150037302
    Abstract: The present invention relates to a method of producing biosurfactants, such as surfactin, comprising culturing at least one biosurfactant-producing microbe in a liquid culture medium comprising vinasse as a carbon source. Methods of using the crude biosurfactant containing culture broth in tertiary oil recovery and as antibacterial compositions in tertiary oil recovery are also described. Methods of using the culture broth residue after isolation of the biosurfactants as fertilizer and compositions for this use are also described.
    Type: Application
    Filed: January 25, 2013
    Publication date: February 5, 2015
    Inventors: Michael Paul Bralkowski, Sarah Ashley Brooks, Stephen M. Hinton, David Matthew Wright, Shih-Hsin Yang
  • Publication number: 20150037307
    Abstract: The present invention relates to methods of improving the environment within a poultry farming facility including reducing ammonia production in a poultry facility, inhibiting urease enzymes in poultry litter, reducing levels of pathogenic bacteria in poultry litter, improving productivity of poultry farms, reducing or preventing pododermatitis in poultry reared in mass production poultry facilities and controlling pests in poultry litter. Compositions, suitable for use in such methods, comprising at least one microorganism of the genus Bacillus and at least one biosurfactant wherein the biosurfactant is present in an amount of 2 mg/L to 7000 mg/L are also described.
    Type: Application
    Filed: January 25, 2013
    Publication date: February 5, 2015
    Inventors: Michael Paul Bralkowski, Sarah Ashley Brooks, Stephen M. Hinton, David Matthew Wright, Shih-Hsin Yang
  • Patent number: D889639
    Type: Grant
    Filed: April 19, 2019
    Date of Patent: July 7, 2020
    Assignee: Merit Medical Systems, Inc.
    Inventors: David W. Johnson, Sarah Ashley Spangler